chocolate consumption level
Behaviorallevel of consumption of 1 oz. of chocolate, as assessed at baseline
NCT Number: NCT03453073
The investigators will conduct an epidemiological analysis of data from the Women's Health Initiative to investigate the prospective association between chocolate intake and the risk of heart disease and stroke.
Looking for future studies?
Notify Me55 year–79 year
Female
Observational
BACKGROUND: Three recent meta-analyses found significant prospective inverse associations between chocolate intake and cardiovascular disease risk. Evidence from these meta-analyses suggests that such inverse associations may only apply to elderly individuals or those with preexisting major chronic disease.
OBJECTIVE: The investigators will assess the association between habitual chocolate intake and subsequent incident coronary heart disease (CHD) and stroke, and the potential effect of modification by age.
DESIGN: The investigators will conduct multivariable Cox regression analyses using data from 83,310 postmenopausal women free of baseline preexisting major chronic disease in the prospective Women's Health Initiative cohort. Chocolate intake was assessed using a food frequency questionnaire. Physician adjudicated events or deaths were ascertained up to September 30, 2013.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
level of consumption of 1 oz. of chocolate, as assessed at baseline
Time frame: between the baseline survey (1993-8) & September 30, 2013, average 13.4 years
physician adjudicated first occurrence of, or death due to, heart disease
Time frame: between the baseline survey (1993-8) & September 30, 2013, average 13.4 years
physician adjudicated first occurrence of, or death due to, stroke
Time frame: between the baseline survey (1993-8) & September 30, 2013, average 13.4 years
physician adjudicated first occurrence of, or death due to, heart disease or stroke
Time frame: time between the baseline and visit 3, average 3 years
change in chocolate intake between visit 1 and 3
Time frame: time between the baseline and year 3, average 3 years
change in dietary energy intake between visit 1 and 3
Time frame: time between the baseline and year 3, average 3 years
change in dietary fat intake between visit 1 and 3
Time frame: time between the baseline and year 3, average 3 years
change in BMI between visit 1 and 3
Brooklyn College of the City University of New York
Other
Chocolate Intake and Heart Disease and Stroke in the Women's Health Initiative: a Prospective Analysis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01715376
Angina Pectoris, Arterial Occlusive Diseases
Changchun, Jilin, China
View Trial DetailsNCT00121550
Cardiovascular Disease, Cardiovascular Diseases
Copenhagen, Denmark
View Trial DetailsNCT02694094
Brain Diseases, Cardiovascular Disease
Baltimore, Maryland, United States
View Trial DetailsNCT00701220
Cardiomyopathies, Cardiomyopathy
Columbus, Ohio, United States
View Trial Details